8-K Announcements
6Apr 22, 2026·SEC
Apr 16, 2026·SEC
Feb 25, 2026·SEC
AMERISAFE, Inc. (AMSF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AMERISAFE, Inc. (AMSF) stock price & volume — 10-year historical chart
AMERISAFE, Inc. (AMSF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
AMERISAFE, Inc. (AMSF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $0.50vs $0.52-3.8% | $89Mvs $90M-2.2% |
| Q1 2026 | Feb 25, 2026 | $0.51vs $0.57-10.5% | $70Mvs $67M+4.4% |
| Q4 2025 | Oct 29, 2025 | $0.55vs $0.55+0.0% | $82Mvs $80M+2.4% |
| Q3 2025 | Jul 24, 2025 | $0.53vs $0.55-3.6% | $81Mvs $78M+3.8% |
AMERISAFE, Inc. (AMSF) competitors in Specialty Commercial P&C Carriers — business model, growth, and fundamentals comparison
AMERISAFE, Inc. (AMSF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMERISAFE, Inc. (AMSF) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 375.21M | 377.75M | 370.37M | 339.5M | 316.01M | 294.69M | 306.91M | 309.11M | 317.25M | 324.76M |
| Revenue Growth % | -5.41% | 0.68% | -1.95% | -8.33% | -6.92% | -6.75% | 4.15% | 0.72% | 2.63% | 7.82% |
| Medical Costs & Claims | 234.14M | 231.05M | 201.35M | 0 | 160.8M | 152.32M | 0 | 181.02M | 169.94M | 170.16M |
| Medical Cost Ratio % | 62.4% | 61.16% | 54.37% | 0% | 50.88% | 51.69% | 0% | 58.56% | 53.57% | 52.4% |
| Gross Profit | 141.07M▲ 0% | 146.7M▲ 4.0% | 169.02M▲ 15.2% | 339.5M▲ 100.9% | 155.22M▼ 54.3% | 142.38M▼ 8.3% | 306.91M▲ 115.6% | 128.09M▼ 58.3% | 147.31M▲ 15.0% | 154.57M▲ 0% |
| Gross Margin % | 37.6% | 38.84% | 45.63% | 100% | 49.12% | 48.31% | 100% | 41.44% | 46.43% | 47.59% |
| Gross Profit Growth % | -17.69% | 3.99% | 15.21% | 100.87% | -54.28% | -8.27% | 115.56% | -58.26% | 15.01% | - |
| Operating Expenses | 58.83M | 59.12M | 53.5M | 232.59M | 75.77M | 74.73M | 229.53M | 59.04M | 88.46M | 96.78M |
| OpEx / Revenue % | 15.68% | 15.65% | 14.45% | 68.51% | 23.98% | 25.36% | 74.79% | 19.1% | 27.88% | 29.8% |
| Depreciation & Amortization | 984K | 996K | 942K | 0 | 1.02M | 1.31M | 1.43M | 1.09M | 742K | 528K |
| Combined Ratio % | 78.08% | 76.82% | 68.81% | 68.51% | 74.86% | 77.05% | 74.79% | 77.66% | 81.45% | 82.19% |
| Operating Income | 82.24M▲ 0% | 87.58M▲ 6.5% | 115.52M▲ 31.9% | 106.92M▼ 7.4% | 79.45M▼ 25.7% | 67.65M▼ 14.9% | 77.38M▲ 14.4% | 69.06M▼ 10.8% | 58.85M▼ 14.8% | 57.79M▲ 0% |
| Operating Margin % | 21.92% | 23.18% | 31.19% | 31.49% | 25.14% | 22.95% | 25.21% | 22.34% | 18.55% | 17.79% |
| Operating Income Growth % | -27.11% | 6.49% | 31.9% | -7.44% | -25.69% | -14.86% | 14.39% | -10.75% | -14.78% | - |
| EBITDA | 83.22M | 88.58M | 116.46M | 106.92M | 80.47M | 68.95M | 78.8M | 70.15M | 59.59M | 58.32M |
| EBITDA Margin % | 22.18% | 23.45% | 31.44% | 31.49% | 25.46% | 23.4% | 25.68% | 22.69% | 18.78% | 17.96% |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 78.8M | 0 | 0 | 0 |
| Pretax Income | 82.24M▲ 0% | 87.58M▲ 6.5% | 115.52M▲ 31.9% | 106.92M▼ 7.4% | 79.45M▼ 25.7% | 67.65M▼ 14.9% | 77.38M▲ 14.4% | 69.06M▼ 10.8% | 58.85M▼ 14.8% | 57.79M▲ 0% |
| Pretax Margin % | 21.92% | 23.18% | 31.19% | 31.49% | 25.14% | 22.95% | 25.21% | 22.34% | 18.55% | 17.79% |
| Income Tax | 36.01M | 15.95M | 22.83M | 20.32M | 13.69M | 12.04M | 15.27M | 13.62M | 11.71M | 11.45M |
| Effective Tax Rate % | 43.79% | 18.21% | 19.76% | 19% | 17.23% | 17.8% | 19.73% | 19.72% | 19.89% | 19.81% |
| Net Income | 46.23M▲ 0% | 71.63M▲ 54.9% | 92.69M▲ 29.4% | 86.6M▼ 6.6% | 65.76M▼ 24.1% | 55.6M▼ 15.4% | 62.11M▲ 11.7% | 55.44M▼ 10.7% | 47.15M▼ 15.0% | 46.34M▲ 0% |
| Net Margin % | 12.32% | 18.96% | 25.03% | 25.51% | 20.81% | 18.87% | 20.24% | 17.93% | 14.86% | 14.27% |
| Net Income Growth % | -40.63% | 54.94% | 29.4% | -6.57% | -24.07% | -15.44% | 11.7% | -10.74% | -14.96% | -2.36% |
| EPS (Diluted) | 2.40▲ 0% | 3.71▲ 54.6% | 4.80▲ 29.4% | 4.47▼ 6.9% | 3.39▼ 24.2% | 2.88▼ 15.0% | 3.23▲ 12.2% | 2.89▼ 10.5% | 2.47▼ 14.5% | 2.46▲ 0% |
| EPS Growth % | -40.74% | 54.58% | 29.38% | -6.88% | -24.16% | -15.04% | 12.15% | -10.53% | -14.53% | -2.02% |
| EPS (Basic) | 2.41 | 3.73 | 4.82 | 4.49 | 3.40 | 2.89 | 3.24 | 2.91 | 2.48 | - |
| Diluted Shares Outstanding | 19.25M | 19.29M | 19.33M | 19.36M | 19.41M | 19.32M | 19.23M | 19.16M | 19.08M | 18.86M |
AMERISAFE, Inc. (AMSF) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 1.43B | 1.42B | 1.42B | 1.38B | 1.3B | 1.15B | 1.11B | 1.05B | 1.03B | 209.44M |
| Asset Growth % | -0.63% | -0.96% | -0.4% | -2.16% | -6.06% | -11.36% | -3.9% | -5.27% | -1.62% | -94.55% |
| Total Investment Assets | 1.13B | 1.13B | 1.13B | 1.09B | 1.01B | 888.99M | 857.79M | 788.78M | 734.86M | 4M |
| Long-Term Investments | 1.13B | 1.13B | 1.13B | 1.09B | 1.01B | 888.99M | 857.79M | 788.78M | 734.86M | 2.26B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 314.21M |
| Total Current Assets | 229.79M | 202.82M | 201.77M | 218.52M | 205.82M | 183.18M | 171.54M | 186.7M | 222.87M | 530.84M |
| Cash & Equivalents | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M | 34.23M |
| Receivables | 174.23M | 162.48M | 157.95M | 156.76M | 135.1M | 121.71M | 132.86M | 142.66M | 160.94M | 670.38M |
| Other Current Assets | 432.38M | 365.56M | 345.2M | 397.94M | 379.86M | 276.88M | 271.6M | 278.66M | 0 | 7.2M |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.09M | 21.09M |
| Goodwill | 0 | 1.09B | 0 | 1.06B | 987.78M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.09M | 0 |
| PP&E (Net) | 6.13M | 6.26M | 6.76M | 6.5M | 6.65M | 7.33M | 6.38M | 6.16M | 7.5M | 7.14M |
| Other Assets | 42.61M | 47.5M | 45.94M | 37.63M | 42.73M | 41.31M | 43.09M | 39.68M | 18.56M | 0 |
| Total Liabilities | 1.09B | 1.11B | 1.06B | 1.03B | 1B | 951.85M | 936.71M | 900.45M | 878.95M | -913.52M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 491K | 0 |
| Net Debt | -55.56M | -40.34M | -43.81M | -61.76M | -70.72M | -61.47M | -38.68M | -44.05M | -61.44M | -34.23M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 801.34M | 747.85M | 687.71M | 680.77M | 700.73M | 0 |
| Accounts Payable | 37.08M | 38.61M | 40.09M | 0 | 37.88M | 38.06M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 121.09M | 114.98M | 116.58M | 121.93M | 135.5M | 0 |
| Other Current Liabilities | -41.35M | -31.67M | -26.19M | -417K | 642.36M | 594.81M | 571.13M | 558.85M | 565.23M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 202.06M | 204M | 249M | 219.68M | 178.22M | -913.52M |
| Total Equity | 425.42M▲ 0% | 409.76M▼ 3.7% | 430.21M▲ 5.0% | 438.82M▲ 2.0% | 399.32M▼ 9.0% | 317.43M▼ 20.5% | 292.45M▼ 7.9% | 257.34M▼ 12.0% | 251.6M▼ 2.2% | 1.12B▲ 0% |
| Equity Growth % | -6.74% | -3.68% | 4.99% | 2% | -9% | -20.51% | -7.87% | -12.01% | -2.23% | 303.96% |
| Shareholders Equity | 425.42M | 409.76M | 430.21M | 438.82M | 399.32M | 317.43M | 292.45M | 257.34M | 251.6M | 1.12B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 233.9M | 221.33M | 227.16M | 224.65M | 190.49M | 145.51M | 114.29M | 84.11M | 82.85M | 0 |
| Common Stock | 204K | 205K | 205K | 206K | 206K | 207K | 207K | 207K | 208K | 208K |
| Accumulated OCI | 3.61M | -832K | 12.21M | 21.02M | 13.54M | -13.83M | -7.19M | -8.88M | -3.22M | -5.67M |
| Return on Equity (ROE) | 10.49% | 17.15% | 22.07% | 19.93% | 15.69% | 15.51% | 20.37% | 20.17% | 18.53% | 9.68% |
| Return on Assets (ROA) | 3.21% | 5.02% | 6.54% | 6.19% | 4.9% | 4.53% | 5.49% | 5.14% | 4.53% | 5.56% |
| Equity / Assets | 29.65% | 28.84% | 30.4% | 31.69% | 30.7% | 27.53% | 26.39% | 24.51% | 24.36% | 536.18% |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | 0.00x |
| Book Value per Share | 22.10 | 21.24 | 22.26 | 22.66 | 20.57 | 16.43 | 15.21 | 13.43 | 13.18 | 59.53 |
| Tangible BV per Share | 22.10 | -35.27 | 22.26 | -32.27 | -30.32 | 16.43 | 15.21 | 13.43 | 12.08 | 59.53 |
AMERISAFE, Inc. (AMSF) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 130.81M | 98.27M | 78.82M | 63.4M | 37.98M | 28.19M | 29.84M | 24.19M | 11.07M | 11.07M |
| Operating CF Growth % | 14.53% | -24.88% | -19.79% | -19.57% | -40.09% | -25.76% | 5.85% | -18.94% | -54.24% | -251.75% |
| Operating CF / Revenue % | 34.86% | 26.01% | 21.28% | 18.67% | 12.02% | 9.57% | 9.72% | 7.83% | 3.49% | 3.41% |
| Net Income | 46.23M | 71.63M | 92.69M | 86.6M | 65.76M | 55.6M | 62.11M | 55.44M | 47.15M | 46.34M |
| Depreciation & Amortization | 984K | 996K | 942K | 1.01M | 1.02M | 1.31M | 1.43M | 1.09M | 742K | 703K |
| Stock-Based Compensation | 2.02M | 2.06M | 2.35M | 3.3M | 2.32M | 2.48M | 1.56M | 2.94M | 2.91M | 2.42M |
| Deferred Taxes | 12.8M | -1.46M | 872K | 1.66M | 1.27M | -1.14M | 628K | 1.4M | 372K | 364K |
| Other Non-Cash Items | 14.66M | 14.41M | 3.98M | 2.87M | -5.24M | 11.44M | -4.84M | -7.34M | -6.23M | -21.13M |
| Working Capital Changes | 54.11M | 10.63M | -22.02M | -32.04M | -27.14M | -41.5M | -31.04M | -29.34M | -33.86M | -18.53M |
| Cash from Investing | -51.54M | -29.06M | 11.69M | 43.37M | 70.96M | 75.43M | 43.88M | 72.37M | 68.42M | 46M |
| Capital Expenditures | -478K | -1.13M | -1.02M | -921K | -1.3M | -2.09M | -553K | -840K | -2.15M | -2.17M |
| Acquisitions | -78.9M | -100.11M | -159.7M | -104.56M | 23K | -85.01M | -44.44M | 0 | 0 | 0 |
| Purchase of Investments | -401.81M | -368.27M | -345.9M | -320.95M | -271.18M | -215.48M | -133.68M | -110.7M | -67M | -91.82M |
| Sale/Maturity of Investments | 350.75M | 340.34M | 358.61M | 365.24M | 343.41M | 293M | 178.12M | 112.84M | 72.55M | 96.31M |
| Other Investing | 78.9M | 100.11M | 159.7M | 104.56M | 0 | 85.01M | 44.44M | 71.07M | 65.02M | 43.69M |
| Cash from Financing | -82.64M | -84.42M | -87.04M | -88.83M | -99.97M | -112.87M | -96.51M | -91.2M | -61.61M | -66.69M |
| Dividends Paid | -82.64M | -84.49M | -87.02M | -88.78M | -99.93M | -100.43M | -93.31M | -85.44M | -48.61M | -48.95M |
| Share Repurchases | 0 | 0 | -20K | 0 | 0 | -12.39M | -2.17M | -5.68M | -12.1M | -12.1M |
| Stock Issued | 0 | 67K | 20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 0 | -47K | -50K | -44K | -58K | -91K | -85K | -85K | -64K |
| Other Financing | 0 | 67K | 20K | 0 | 0 | 0 | -944K | -554K | -817K | -5.58M |
| Net Change in Cash | -3.38M▲ 0% | -15.21M▼ 350.5% | 3.47M▲ 122.8% | 17.94M▲ 417.3% | 8.96M▼ 50.0% | -9.25M▼ 203.2% | -22.79M▼ 146.3% | 5.36M▲ 123.5% | 17.88M▲ 233.4% | -10.53M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 58.94M | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M |
| Cash at End | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M | 34.23M |
| Free Cash Flow | 130.33M▲ 0% | 97.14M▼ 25.5% | 77.81M▼ 19.9% | 62.48M▼ 19.7% | 36.68M▼ 41.3% | 26.11M▼ 28.8% | 29.29M▲ 12.2% | 23.35M▼ 20.3% | 8.92M▼ 61.8% | 7.99M▲ 0% |
| FCF Growth % | 15.77% | -25.47% | -19.9% | -19.7% | -41.29% | -28.84% | 12.2% | -20.28% | -61.79% | -45.99% |
| FCF Margin % | 34.74% | 25.72% | 21.01% | 18.4% | 11.61% | 8.86% | 9.54% | 7.55% | 2.81% | 2.46% |
| FCF per Share | 6.77 | 5.04 | 4.03 | 3.23 | 1.89 | 1.35 | 1.52 | 1.22 | 0.47 | 0.47 |
AMERISAFE, Inc. (AMSF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 78.08% | 76.82% | 68.81% | 68.51% | 74.86% | 77.05% | 74.79% | 77.66% | 81.45% | 82.19% |
| Medical Cost Ratio | 62.4% | 61.16% | 54.37% | 0% | 50.88% | 51.69% | 0% | 58.56% | 53.57% | 52.4% |
| Return on Equity (ROE) | 10.49% | 17.15% | 22.07% | 19.93% | 15.69% | 15.51% | 20.37% | 20.17% | 18.53% | 9.68% |
| Return on Assets (ROA) | 3.21% | 5.02% | 6.54% | 6.19% | 4.9% | 4.53% | 5.49% | 5.14% | 4.53% | 5.56% |
| Equity / Assets | 29.65% | 28.84% | 30.4% | 31.69% | 30.7% | 27.53% | 26.39% | 24.51% | 24.36% | 536.18% |
| Book Value / Share | 22.1 | 21.24 | 22.26 | 22.66 | 20.57 | 16.43 | 15.21 | 13.43 | 13.18 | 59.53 |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | 0.00x |
| Revenue Growth | -5.41% | 0.68% | -1.95% | -8.33% | -6.92% | -6.75% | 4.15% | 0.72% | 2.63% | 7.82% |
AMERISAFE, Inc. (AMSF) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 22, 2026·SEC
Apr 16, 2026·SEC
Feb 25, 2026·SEC
AMERISAFE, Inc. (AMSF) stock FAQ — growth, dividends, profitability & financials explained
AMERISAFE, Inc. (AMSF) grew revenue by 2.6% over the past year. Growth has been modest.
Yes, AMERISAFE, Inc. (AMSF) is profitable, generating $46.3M in net income for fiscal year 2025 (14.9% net margin).
Yes, AMERISAFE, Inc. (AMSF) pays a dividend with a yield of 8.57%. This makes it attractive for income-focused investors.
AMERISAFE, Inc. (AMSF) has a return on equity (ROE) of 18.5%. This is reasonable for most industries.
AMERISAFE, Inc. (AMSF) has a combined ratio of 81.4%. A ratio below 100% indicates underwriting profitability.
AMERISAFE, Inc. (AMSF) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates